Showing results (221-230 of 287) with videos related to
Sort By:
Pageof 29
Schizophrenia Bulletin|September 19, 2000
A 39-year followup of the Genain quadrupletsA F Mirsky, L A Bieliauskas, L M French, et al.Biological Psychiatry|February 15, 1993
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patientsA L Nordström, L Farde, F A Wiesel, et al.Nuclear Medicine Communications|October 19, 2001
Reproducibility of [11 C]FLB 457 binding in extrastriatal regionsY Sudo, T Suhara, M Inoue, et al.Psychopharmacology|August 6, 2000
High 5HT2A receptor occupancy in M100907-treated schizophrenic patientsM Talvik-Lotfi, S Nyberg, A L Nordström, et al.Nuclear Medicine and Biology|July 1, 1993
Preparation of [1-11C]dopamine, [1-11C]p-tyramine and [1-11C]m-tyramine. Autoradiography and PET examination of [1-11C]dopamine in primatesK O Schoeps, C Halldin, K Någren, et al.European Journal of Nuclear Medicine|June 1, 1997
In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brainK A Bergström, C Halldin, H Hall, et al.Acta Biologica Hungarica|June 18, 2002
Autoradiographic evaluation of [11C]vinpocetine binding in the human postmortem brainH Hall, K Varnäs, J Sandell, et al.Journal of Clinical Psychopharmacology|August 5, 1998
Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brainB Andrée, S Nyberg, H Ito, et al.Psychopharmacology|October 29, 1997
PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brainL Farde, N Ginovart, H Ito, et al.Orvosi Hetilap|August 26, 1999
[Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies]B Gulyás, C Halldin, P Karlsson, et al.Pageof 29